Shares

14 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2021

Feb 15, 2022

SELL
$4.58 - $8.34 $41,920 - $76,336
-9,153 Closed
0 $0
Q3 2021

Jun 21, 2023

BUY
$8.44 - $18.35 $77,251 - $167,957
9,153 New
9,153 $77,000
Q2 2021

Jun 21, 2023

BUY
$16.41 - $24.71 $150,200 - $226,170
9,153 New
9,153 $150,000
Q2 2021

Mar 30, 2023

BUY
$16.41 - $24.71 $19,609 - $29,528
1,195 Added 15.02%
9,153 $150,000
Q2 2021

Aug 16, 2021

BUY
$16.41 - $24.71 $150,069 - $225,972
9,145 Added 114312.5%
9,153 $150,000
Q1 2021

Jun 26, 2023

BUY
$20.38 - $34.07 $162,184 - $271,129
7,958 New
7,958 $176 Million
Q1 2021

May 14, 2021

SELL
$20.38 - $34.07 $162,021 - $270,856
-7,950 Reduced 99.9%
8 $176,000
Q4 2020

Jun 22, 2023

BUY
$19.0 - $32.63 $151,202 - $259,669
7,958 New
7,958 $246,000
Q3 2020

Jun 26, 2023

BUY
$13.1 - $20.69 $104,249 - $164,651
7,958 New
7,958 $161,000
Q3 2020

Mar 30, 2023

BUY
$13.1 - $20.69 $29,972 - $47,338
2,288 Added 40.35%
7,958 $161,000
Q3 2020

Nov 13, 2020

BUY
$13.1 - $20.69 $29,972 - $47,338
2,288 Added 40.35%
7,958 $162,000
Q2 2020

Jun 26, 2023

BUY
$6.51 - $16.85 $36,911 - $95,539
5,670 New
5,670 $87,000
Q2 2020

Mar 30, 2023

BUY
$6.51 - $16.85 $36,911 - $95,539
5,670 New
5,670 $87,000
Q2 2020

Aug 14, 2020

BUY
$6.51 - $16.85 $36,911 - $95,539
5,670 New
5,670 $87,000

About TCR2 THERAPEUTICS INC.


  • Ticker TCRR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 38,606,400
  • Description
  • TCR2 Therapeutics Inc., a clinical-stage immunotherapy company, focuses on developing novel T cell receptor (TCR) therapies for patients suffering from cancer. The company's lead product candidates include gavo-cel, a mono TCR Fusion Construct T cells (TRuC-T cells) targeting mesothelin positive solid tumors, which is in phase I/II clinical tria...
More about TCRR
Track This Portfolio

Track Metropolitan Life Insurance CO Portfolio

Follow Metropolitan Life Insurance CO and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Metropolitan Life Insurance CO, based on Form 13F filings with the SEC.

News

Stay updated on Metropolitan Life Insurance CO with notifications on news.